Difference between revisions of "Part:BBa K2549005:Design"

 
(→‎References)
Line 16: Line 16:
  
 
===References===
 
===References===
 +
[1]Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia; Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia; Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia.
 +
.
 +
N Engl J Med, 2016 Mar;374(10):998  PMID: 26962747; DOI: 10.1056/NEJMx160005

Revision as of 02:29, 3 October 2018


anti-CD19


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 444


Design Notes

Its heavy-chain variable region(αCD19a) and light-chain variable region(αCD19b) are fused using a glycine-rich peptide linker(3 repeats of GGGGS, or G4S).


Source

IDT(gBlock)

References

[1]Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia; Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia; Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia. . N Engl J Med, 2016 Mar;374(10):998 PMID: 26962747; DOI: 10.1056/NEJMx160005